|
PMS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.42090039523657E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28669999497089E-08 |
| Normal-vs-Stage2 |
8.663100E-03 |
| Normal-vs-Stage3 |
2.128000E-01 |
| Normal-vs-Stage4 |
9.923000E-01 |
| Stage1-vs-Stage2 |
5.419400E-01 |
| Stage1-vs-Stage3 |
4.168200E-02 |
| Stage1-vs-Stage4 |
5.118300E-02 |
| Stage2-vs-Stage3 |
6.583800E-02 |
| Stage2-vs-Stage4 |
5.598100E-02 |
| Stage3-vs-Stage4 |
4.491600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.23420001890895E-09 |
| Normal-vs-AfricanAmerican |
1.394950E-04 |
| Normal-vs-Asian |
3.146600E-01 |
| Caucasian-vs-AfricanAmerican |
9.990600E-01 |
| Caucasian-vs-Asian |
5.751000E-01 |
| AfricanAmerican-vs-Asian |
6.062000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58400004224291E-09 |
| Normal-vs-Female |
4.29739999999734E-05 |
| Male-vs-Female |
8.067600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.636800E-04 |
| Normal-vs-Extreme_Weight |
6.10009999999495E-05 |
| Normal-vs-Obese |
6.24679999999822E-05 |
| Normal-vs-Extreme_Obese |
8.099900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.771200E-01 |
| Normal_Weight-vs-Obese |
9.904800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.219200E-01 |
| Extreme_Weight-vs-Obese |
8.490400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.069800E-01 |
| Obese-vs-Extreme_Obese |
6.921000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.375600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.94369997664046E-10 |
| Normal-vs-Age(61-80Yrs) |
8.63509999948775E-07 |
| Normal-vs-Age(81-100Yrs) |
3.693000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.759400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.908000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.508400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.901040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.250430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.778000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.620000E-01 |
| Normal-VS-KIRP CIMP |
3.573400E-01 |
| Normal-VS-Unclassified PRCC |
2.198200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.00329966556956E-10 |
| Type1 PRCC-VS-KIRP CIMP |
8.30259999999861E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.495130E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.630400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.072420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.839900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.002500E-02 |
| Normal-vs-N1 |
7.085800E-01 |
| Normal-vs-N2 |
7.633000E-01 |
| N0-vs-N1 |
1.256440E-01 |
| N0-vs-N2 |
3.263400E-01 |
| N1-vs-N2 |
7.339400E-01 |
|
|
